Bartosz Puła

2.4k total citations
138 papers, 1.6k citations indexed

About

Bartosz Puła is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Bartosz Puła has authored 138 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 38 papers in Oncology and 37 papers in Genetics. Recurrent topics in Bartosz Puła's work include Chronic Lymphocytic Leukemia Research (33 papers), Lymphoma Diagnosis and Treatment (24 papers) and Trace Elements in Health (20 papers). Bartosz Puła is often cited by papers focused on Chronic Lymphocytic Leukemia Research (33 papers), Lymphoma Diagnosis and Treatment (24 papers) and Trace Elements in Health (20 papers). Bartosz Puła collaborates with scholars based in Poland, United States and Germany. Bartosz Puła's co-authors include Piotr Dzięgiel, Marzenna Podhorska‐Okołów, Christopher Kobierzycki, Andrzej Wojnar, Aleksandra Piotrowska, Wojciech Witkiewicz, Maciej Ugorski, Janusz Ryś, Krzysztof Jamroziak and Agnieszka Gomułkiewicz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Bartosz Puła

126 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bartosz Puła Poland 23 724 505 282 229 218 138 1.6k
Andrea Pellacani Italy 21 1.0k 1.4× 237 0.5× 175 0.6× 178 0.8× 257 1.2× 48 2.1k
Elke Pravda United States 12 700 1.0× 479 0.9× 167 0.6× 214 0.9× 96 0.4× 13 2.0k
Martin R. Weihrauch Germany 21 443 0.6× 476 0.9× 131 0.5× 132 0.6× 417 1.9× 40 1.8k
Christos Adamopoulos Greece 28 887 1.2× 272 0.5× 227 0.8× 107 0.5× 336 1.5× 57 2.0k
Kimberly J. Krager United States 19 990 1.4× 255 0.5× 213 0.8× 86 0.4× 61 0.3× 42 2.1k
Deguan Li China 23 803 1.1× 229 0.5× 336 1.2× 59 0.3× 64 0.3× 65 1.8k
Allan S. Pollock United States 25 805 1.1× 275 0.5× 371 1.3× 110 0.5× 91 0.4× 39 2.0k
Ingo Melzner Germany 20 776 1.1× 421 0.8× 188 0.7× 67 0.3× 379 1.7× 45 1.9k
Marie Brevet France 27 833 1.2× 816 1.6× 386 1.4× 89 0.4× 321 1.5× 76 2.8k

Countries citing papers authored by Bartosz Puła

Since Specialization
Citations

This map shows the geographic impact of Bartosz Puła's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bartosz Puła with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bartosz Puła more than expected).

Fields of papers citing papers by Bartosz Puła

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bartosz Puła. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bartosz Puła. The network helps show where Bartosz Puła may publish in the future.

Co-authorship network of co-authors of Bartosz Puła

This figure shows the co-authorship network connecting the top 25 collaborators of Bartosz Puła. A scholar is included among the top collaborators of Bartosz Puła based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bartosz Puła. Bartosz Puła is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iskierka‐Jazdzewska, Elżbieta, Krzysztof Jamroziak, Tadeusz Robak, & Bartosz Puła. (2025). Zapobieganie i leczenie działań niepożądanych związanych z terapią skojarzoną ibrutynibem i wenetoklaksem w przewlekłej białaczce limfocytowej. SHILAP Revista de lepidopterología. 5(1-2). 53–65.
2.
3.
Robak, Tadeusz, et al.. (2025). The Development of Novel Therapies for Chronic Lymphocytic Leukaemia in the Era of Targeted Drugs. Journal of Clinical Medicine. 14(22). 8247–8247.
4.
Puła, Bartosz, et al.. (2024). Update on management of diffuse large B-cell lymphoma Richter's transformation. Acta Haematologica Polonica. 55(2). 97–107. 1 indexed citations
5.
Puła, Bartosz, Elżbieta Iskierka‐Jazdzewska, Krzysztof Jamroziak, et al.. (2024). Expert opinion on use of acalabrutinib for chronic lymphocytic leukemia treatment. Acta Haematologica Polonica. 55(3). 130–136. 2 indexed citations
6.
Puła, Bartosz. (2024). What’s new in chronic myelogenous leukemia and COVID-19?. Acta Haematologica Polonica. 55(2). 59–59. 1 indexed citations
7.
8.
Puła, Bartosz, et al.. (2021). Harmonization of Flow Cytometric Minimal Residual Disease Assessment in Multiple Myeloma in Centers of Polish Myeloma Consortium. Diagnostics. 11(10). 1872–1872. 5 indexed citations
9.
Masternak, Michał M., Bartosz Puła, Anna Waszczuk‐Gajda, et al.. (2020). Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Machnicki, Marcin M., Patryk Górniak, Agnieszka Szymczyk, et al.. (2020). Predictive significance of selected gene mutations in relapsed and refractory chronic lymphocytic leukemia patients treated with ibrutinib. European Journal Of Haematology. 106(3). 320–326. 3 indexed citations
11.
Kobierzycki, Christopher, Jędrzej Grzegrzółka, Bartosz Puła, et al.. (2016). SOX18 Expression in Non-melanoma Skin Cancer.. PubMed. 36(5). 2379–83. 16 indexed citations
12.
Szepietowski, Jacek C., et al.. (2016). Expression of Podoplanin in Non-melanoma Skin Cancers and Actinic Keratosis.. PubMed. 36(4). 1591–7. 9 indexed citations
13.
Puła, Bartosz, Andrzej Bieniek, Jacek C. Szepietowski, et al.. (2014). Metallothionein 3 Expression in Normal Skin and Malignant Skin Lesions. Pathology & Oncology Research. 21(1). 187–193. 13 indexed citations
14.
Wojnar, Andrzej, Bartosz Puła, Marzenna Podhorska‐Okołów, & Piotr Dzięgiel. (2013). Discrepancies between HER2 assessment from core needle biopsies and surgical specimens of invasive ductal breast carcinoma.. PubMed. 22(1). 27–31. 2 indexed citations
15.
Puła, Bartosz, et al.. (2013). Rola ekspresji metalotionein w rakach przewodu pokarmowego. Postepy Biologii Komorki. 40(1). 2 indexed citations
16.
Puła, Bartosz, Andrzej Wojnar, Aleksandra Ambicka, et al.. (2013). Impact of different tumour stroma assessment methods regarding podoplanin expression on clinical outcome in patients with invasive ductal breast carcinoma.. PubMed. 33(4). 1447–55. 14 indexed citations
17.
Szaflarski, Witold, Patrycja Sujka‐Kordowska, Bartosz Puła, et al.. (2013). Expression profiles of vault components MVP, TEP1 and vPARP and their correlation to other multidrug resistance proteins in ovarian cancer. International Journal of Oncology. 43(2). 513–520. 15 indexed citations
18.
Bieniek, Andrzej, et al.. (2012). Expression of metallothionein I/II and Ki-67 antigen in various histological types of basal cell carcinoma. Folia Histochemica et Cytobiologica. 50(3). 352–357. 13 indexed citations
19.
Podhorska‐Okołów, Marzenna, et al.. (2010). Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers.. SHILAP Revista de lepidopterología. 5 indexed citations
20.
Wojnar, Andrzej, et al.. (2010). Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers.. Folia Histochemica et Cytobiologica. 48(3). 442–6. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Pellacani Breakdown of academic impact, for papers by Elke Pravda Breakdown of academic impact, for papers by Martin R. Weihrauch Breakdown of academic impact, for papers by Christos Adamopoulos Breakdown of academic impact, for papers by Kimberly J. Krager Breakdown of academic impact, for papers by Deguan Li Breakdown of academic impact, for papers by Allan S. Pollock Breakdown of academic impact, for papers by Ingo Melzner Breakdown of academic impact, for papers by Marie Brevet
Rankless by CCL
2026